Please assess the completion status of the following clinical trial:

Trial Title: A Randomized Control Trial to Evaluate the Efficacy of Autologous Blood Injection Versus Local Corticosteroid Injection for Treatment of Lateral Epicondylitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Cases of lateral epicondylitis.~2. Men and women above fifteen years of age.~Exclusion Criteria:~1. Patients receiving steroid injections within three months before blood injection.~2. A history of substantial trauma.~3. Previously treated by surgery for lateral epicondylitis.~4. Other causes of elbow pain such as osteochondritis dessecans of capitellum, lateral compartment arthrosis, varus instability, radial head arthritis, posterior interosseous nerve syndrome, cervical disc syndrome, synovitis of radiohumeral joint, cervical radiculopathy, fibromyalgia, osteoarthritis of elbow, carpel tunnel syndrome.

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- Autologous blood injection group (Type: EXPERIMENTAL): This is the study group in whom autologous blood injection was injected at lateral epicondylitis site.
- Local corticosteroid injection group (Type: ACTIVE_COMPARATOR): This is the control group in whom the commonly used treatment modality-local corticosteroid injection was given at lateral epicondyle site.

Based on this trial design, predict the completion outcome and termination type (if applicable).